Nature CommunicationsNeurosciencePeer-reviewed journal article
Maintenance of mitochondrial integrity in midbrain dopaminergic neurons governed by a conserved developmental transcription factor
Federico MiozzoiD, Eva P. Valencia-AlarcóniD, Luca StickleyiD, Michaëla Majcin DorcikovaiD, Francesco PetrelliiD, Damla Tas, Nicolas Loncle, Irina Nikonenko, Peter Bou DibiD, Emi NagoshiiD
Abstract
The degeneration of dopaminergic (DA) neurons in the substantia nigra is a hallmark of Parkinsons disease (PD). Dysregulation of developmental transcription factors is implicated in dopaminergic neurodegeneration, but the underlying molecular mechanisms remain largely unknown. Drosophila Fer2 is a prime example of a developmental transcription factor required for the birth and maintenance of midbrain DA neurons. Using an approach combining ChIP-seq, RNA-seq, and genetic epistasis experiments with PD-linked genes, here we demonstrate that Fer2 controls a transcriptional network to maintain mitochondrial structure and function, and thus confers dopaminergic neuroprotection against genetic and oxidative insults. We further show that conditional ablation of Nato3, a mouse homolog of Fer2, in differentiated DA neurons results in locomotor impairments and mitochondrial abnormality in aged mice. Our results reveal the essential and conserved role of Fer2 homologs in the mitochondrial maintenance of midbrain DA neurons, opening new perspectives for modelling and treating PD.
- organism: Drosophila
- organism: mouse
- assay: ChIP-seq
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 20
- FWCI
- 2.11
- Field percentile
- top 12%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Preserved striatal innervation and motor function despite severe loss of nigral dopamine neurons following mitochondrial dysfunction induced by mtDNA mutations
Thomas Paß, Konrad M. Ricke, … Rudolf J. Wiesner·bioRxiv·Jul 7, 2023
- NATO3 protects dopaminergic neurons in mouse in vivo and human in vitro Parkinson's disease models
Eva P. Valencia-Alarcón, Lou C. Duret, … Emi Nagoshi·bioRxiv·Oct 10, 2025
- Transcriptome responses to reduced dopamine in the Substantia Nigra Pars Compacta reveals a potential protective role for dopamine.
M. Koltun, Karol Cichewicz, … Jay Hirsh·bioRxiv·Sep 9, 2019
- Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson's disease
Aditi Verma, Reddy Peera Kommaddi, … Vijayalakshmi Ravindranath·Journal of Neural TransmissionPeer-reviewed·Feb 23, 2023
- Mitochondrial fitness influences neuronal excitability of dopaminergic neurons from patients with idiopathic form of Parkinson's disease
Paula Chlebanowska, Agata Szlaga, … Marcin Majka·bioRxiv·Apr 28, 2023
- Parkinson's disease-related Miro1 mutation induces mitochondrial dysfunction and loss of dopaminergic neurons in vitro and in vivo
Axel Chemla, Giuseppe Arena, … Cláudia Saraiva·BrainPeer-reviewed·Feb 5, 2025